Safety and Efficacy of EXO-CD24 in Preventing Clinical Deterioration in Patients With Mild-Moderate ARDS
Clinical trial NCT05947747 · UNKNOWN
Trial details
- NCT number
- NCT05947747
- Sponsor
- Nano24med
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-04
- Primary completion
- 2025-12-20
- Enrollment
- 90
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.